Erowid References Database
|
McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH.
“Congenital anomalies after prenatal ecstasy exposure”.
Lancet. 1999 Oct 23;354(9188):1441-2.
|
|
Abstract
Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
